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Dhort-term and aortic coarctation in long-term follow-up12
n our study, however, the presence of aortic atresia–mitral
tenosis was associated with increased early mortality but
ot with recurrent arch obstruction. This finding implies that
ith current techniques, we have been able to mitigate
ypoplastic aortic arch as a risk factor for NAO.
The existence of juxtaductal coarctation or a coarctation
helf is reported in more than 80% of the patients with
LHS, especially when the shelf of the ductal-like tissue
ocated opposite the ductus arteriosum is included.4,5 This
issue has the potential to cause late obstruction.22 However,
o standard surgical approach to this defect has been widely
ccepted. Moreover, contradictory data regarding this issue
ave been reported. Burkhart and colleagues23 have recently
eported lower arch obstruction rates in patients undergoing
he Norwood procedure with a technique that includes re-
ection of the posterior shelf. However, Griselli and asso-
iates24 have reported that the type of aortic arch re-
truction did not affect the incidence of need for arch
ntervention. In our study the presence of a preoperative
osterior shelf was significantly associated with NAO and
eed for reintervention, reoperation, or both. Furthermore,
oarctectomy significantly reduced the incidence of NAO.
his association resulted in “effect modification”; that is,
oarctectomy is particularly effective in patients with a
reoperative diagnosis of coarctation. However, echocar-
iographic determination of coarctation at the level of the
mplantation of the ductus arteriosus is very challenging
ecause of the presence of a large ductus and the subsequent
urbulent blood flow at the ductal insertion into the descend-
ng thoracic aorta. Direct inspection might also play a role
n deciding whether coarctectomy should be done. More-
ver, other factors besides resection of coarctation could be
nvolved in the development of NAO in HLHS. In fact, in
ur study the risk of NAO was higher in patients undergoing
esection of coarctation when no preoperative diagnosis of a
osterior shelf was made.
In summary, coarctectomy at the time of stage I pallia-
ion significantly reduces the incidence of NAO, especially
n patients with a preoperative diagnosis of coarctation. Use
f autologous tissue to reconstruct the arch is also associ-
ted with improved outcome. An aggressive approach to
econstruction of the aortic arch at the time of stage I
alliation is advocated.
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iscussion
r James S. Tweddell (Milwaukee, Wis). Interstage survival, as
ell as improved candidacy for stage II palliation, depends on
imiting the development of recurrent or residual lesions addressed
n the initial stage I operation, including the prevention of coronary
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Dhe development of restriction of pulmonary blood flow, and, the
ubject of this presentation, prevention of aortic arch obstruction.
The authors have reviewed a 5½-year experience with 210
atients with HLHS, with special attention to the issue of arch
bstruction. The authors identified a posterior shelf in 47% of these
10 patients, and this was taken as evidence of coarctation.
One theory of coarctation suggests there is migration of ductal
mooth muscle cells into the periductal aorta, with subsequent
onstriction and narrowing of the aortic lumen. Alternatively, in
he case of infantile coarctation, we postulate that the hemody-
amic lesion itself results in an imbalance between the larger
uctus and the smaller adjacent aorta, such that a larger portion of
he junction of these 2 structures is comprised of the ductal tissue,
nd the subsequent ductal involution results in coarctation.
Coarctation can therefore be thought of as one end of the
pectrum of HLHS, and we could postulate an even greater im-
alance in the proportion of ductus and the adjacent aorta, making
oarctation a uniform part of this anomaly. Indeed, as pointed out
n the discussion in your article, it is thought to occur in at least
0% of patients with HLHS. Prosthetic material that crosses this
rea of ductal tissue, which ultimately necroses and fibroses, will
esult in a circumferential ring of nonviable tissue that does not
row and is probably the substrate of recurrent coarctation.
The principal finding of this study was a decrease in the
ncidence of recoarctation in those patients whose posterior shelf
as resected at the time of the stage I palliation. I agree completely
ith the authors’ conclusions that excision of all ductal tissue
educes the risk of recurrent arch obstruction.
I am struck by a couple of findings in this study. First, a
osterior shelf was found in only 90 (47%) of the 210 patients.
his shelf was resected in 55 patients, of whom only 6 required
eintervention for arch obstruction. This left 35 patients with a
osterior shelf who did not undergo resection, and yet 44 addi-
ional patients had recurrent arch obstruction. Therefore some
atients who underwent a resection of the posterior shelf still
equired reintervention, and some patients who had no identifiable
helf still required reintervention.
At the Children’s Hospital of Wisconsin, we use a coarctec-
omy with interdigitation, as described by both our own group and
he group from Toronto Sick Kids Hospital. We have used this
pproach on 67 consecutive patients since July 2002. A little more
han half had aortic atresia. Survival to stage II palliation was
reater than 90%. I say this only to point out that we did not lose
significant number of patients in the interstage period, and
herefore we did not lose patients who might have experienced
rch obstruction had they survived. We have had to reintervene in
one of these patients for arch obstruction. Those data are very
imilar to the data that were reported by the group from Toronto as
ell. The technique therefore is very successful in eliminating that
nterstage problem.
Therefore I have the following questions for you. First, how do
ou know that the posterior shelf resection actually achieves the
oal of complete excision of ductal tissue? Are there other mech-
nisms of arch obstruction that could be at play here?
Dr Bautista-Hernandez. In my opinion the key feature for
eoaortic obstruction is resection of coarctation, but we also think
hat this resection plays a role in avoiding posterior or delayed p
The Journal of Thoracicoarctation, recoarctation. There might be other factors involved,
ut we did not look at those factors specifically in our studies.
Dr Tweddell. Would you care to speculate? I think you had
ome information on the type of additional tissue you used or the
ack of additional tissue?
Dr Bautista-Hernandez. Additional tissue?
Dr Tweddell. Well, you talked about the use of homograft,
ither aortic or pulmonary; autologous pericardium; or no addi-
ional prosthetic material.
Dr Bautista-Hernandez. In our conclusions we show that
utologous tissue, by means of direct connection between the
ulmonary tract and the aorta or the use of autologous pericardium,
as also associated with less recurrence of neoaortic obstruction,
nd therefore we think that autologous tissue is better—is a better
issue to use—than homografts, especially aortic homografts.
Dr Tweddell. In the patients without an obvious posterior
helf, how can you be certain that there is not some residual ductal
issue in that adjacent aortic tissue?
Dr Bautista-Hernandez. The thing is that diagnosis of a
osterior shelf by means of echocardiography is sometimes diffi-
ult because of a large ductus and the subsequent turbulent flow.
herefore, we think that echocardiography is not enough to diag-
ose a posterior shelf. Therefore, the final decision should be done
n the operating room by the surgeon, and sometimes you can see
he posterior shelf, and echocardiography has not been used to
iagnose the coarctation.
Dr Tweddell. Based on this excellent review and your presen-
ation, are you going to consider a more radical resection of the
otential ductal tissue–bearing areas in the future?
Dr Bautista-Hernandez. I think our resection is radical. What
mean is that this technique entails resection, transection of the
orta, resection of ductal tissue, counterincision into the descend-
ng thoracic aorta, and anastomosis between the aortic arch and the
escending thoracic aorta. Therefore maybe we should look at that,
ut we think that it is radical enough.
Dr Glen Van Arsdell (Toronto, Ontario, Canada). I must say
e face this issue as well and had similar obstruction until we did
ull coarctation resection.
I believed that we could not be certain that we were resecting
he entire ductal tissue and therefore made counterincisions to cut
ny potential ductal ring. We actually made 2 counterincisions,
ne posteriorly and one anterolaterally. We call the resulting
nastomosis an “interdigitating repair” (2 areas of interdigitating
amination). Like Dr Tweddell, we have not seen recurrent ob-
truction.
What I would like to talk about is transplantation. We see some
ate ventricular burnout, and those patients have one option: trans-
lantation.
It turns out that they have become sensitized to the HLA
ntigens that are present in the homografts used for arch recon-
truction. You operated on quite a number of patients with autol-
gous pericardium and found that to be favorable. Most surgeons
ould think that it is harder to work with; however, from a
ensitization perspective, it might be more favorable should later
ransplantation be required.
Can you describe to us your technique for use of autologous
ericardium in arch reconstruction?
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DDr Bautista-Hernandez. The pericardium is harvested right
fter the sternotomy and is fixed with glutaraldehyde at 0.6% for
minutes. This procedure allows us to use the pericardium. It is
asier to use, and it is easier to patch the aortic arch in this way.
herefore the description of the procedure is in the article.
Dr Van Arsdell. And bleeding and kinking issues, are there
ny extra issues in that regard?
Dr Pedro del Nido (Boston, Mass). If I could just comment
ecause this is a technical question about the glutaraldehyde. I
hink this is an important question because, obviously, the concern
s aneurysm.
It is autologous pericardium. It is fixed with 0.6% glutaralde-
yde for 10 minutes. The key here is to use as little patch as
ossible. Therefore it is only to bridge the tiny gap in those few
atients in whom direct connection of the pulmonary trunk to the
orta is not made. I think that is a critical point. We did not use
arge patches of pericardium; otherwise, you will see aneurysms.
Dr Charles D. Fraser (Houston, Tex). I have a couple of
houghts and questions related to this series, which sort of high-
ight what we believe; that is, as you have correctly pointed out,
utting autologous tissue together is the best way to repair the arch
n children.
I will say from the initial approach that I was taught by Dr
oger Mee—and that we certainly were very strong proponents of
nitially in Texas when I arrived there—we found that moving the
istal arch and proximal descending aorta together really sort of
liminated the left aortopulmonary window, and we had a lot of
rouble with the left pulmonary artery in that series of patients.
Therefore in the subsequent series of hypoblasts, we really
odified the way we did it, much akin to the way Glen Van
rsdell and Jim Tweddell have described their techniques. There-
ore I wonder what your thoughts are about that. In those patients
n whom you were able to achieve a direct anastomosis, did you
nd more trouble with the left pulmonary artery?
Dr Bautista-Hernandez. Can you repeat, please?
Dr Fraser. Well, if you bring the aorta together, you bring the
ulmonary artery up underneath the aortic arch without any inter-
ening tissue, no patch, no pericardium. Do you find that that
mpinges on the left pulmonary artery more?
Dr Bautista-Hernandez. We used that technique only in 6% of
he patients in our series. Therefore we did that overall in patients
ith favorable anatomy. What I mean is with a large pulmonary t
546 The Journal of Thoracic and Cardiovascular Surgery ● Junrtery trunk and not a diminutive aorta. Therefore we did not see
any problems with the pulmonary branches.
Dr Fraser. The other question that to me has broader impli-
ations is this: Has this experience in your Norwood population
ffected the way you handle arch hypoplasia and other lesions,
uch as transposition?
Dr Bautista-Hernandez. Yes. Dr del Nido, perhaps you would
ike to answer this.
Dr del Nido. This is a critical point, and I think Roger Mee’s
uggestion of using totally autologous tissue was very, very good,
nd we try to follow that concept whenever possible. What we find
s that it is not applicable, at least in our hands, to all patients and
hat you do need a small gusset of patch material, and in that
ituation the pericardium works well.
Has it helped us with our other arch repairs? Absolutely. I think
t has been very helpful for all arch reconstructions, including
ransposition patients with hypoplastic arch.
Dr Carlos J. Troconis (Caracas, Venezuela). Back in the late
970s and early 1980s, this issue of the posterior shelf arose from
he subclavian flap repair for coarctation of aorta. But years after,
he problem still continued, even removing the posterior shelf, as
as recommended by many authors within the technique used.
his issue was abolished after we started to perform extended
nd-to-end anastomosis for neonatal coarctation repair. Therefore
n this track, I think and agree with Dr Tweddell that we should be
ore aggressive with entire resection of the periductal tissue and
osterior shelf, trying to do end-to-end anastomosis whenever
ossible.
Dr Bautista-Hernandez. What we did was an end-to-end
nastomosis between the aortic arch and the descending thoracic
orta. That is what we already did.
Dr Carl Backer (Chicago, Ill). I think that Richard Jonas
rote an editorial about “Should we resect ductal tissue?” in the
iscussion of coarctation, and the answer is yes. That seems to be
rue for HLHS also.
I have several brief questions. How were the patients selected
or one technique or the other? Do you think there was any
election bias? Did certain surgeons prefer one technique over the
ther?
Dr Bautista-Hernandez. Yes, I think so. The decision of
hether to use homograft or autologous tissue was done based onhe surgeon’s preference, and therefore there might be a bias.
e 2007
